Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enantiotracin.

Patrick G McDougal1, John H Griffin

  • 1Department of Chemistry, Stanford University, 94305-5080, Stanford, CA, USA.

Bioorganic & Medicinal Chemistry Letters
|June 12, 2003
PubMed
Summary
This summary is machine-generated.

Researchers synthesized the enantiomer of the antibiotic bacitracin A. This enantiomer showed equal potency in antibacterial assays, suggesting bacitracin targets an achiral molecule.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the binding of skeletal muscle myosin to fibrin in trauma.

The journal of trauma and acute care surgery·2026
Same author

Activated Protein C and the Retina: From Physiology to Therapeutic Potential.

International journal of molecular sciences·2026
Same author

Correction: Activated protein C ameliorates diabetes-induced atherosclerosis by sustaining macrophage efferocytosis.

Cardiovascular diabetology·2026
Same author

Endothelial protein C receptor-mediated endogenous and therapeutic transport of activated protein C across the blood-retina barrier protects the retina.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Activated protein C ameliorates diabetes-induced atherosclerosis by sustaining macrophage efferocytosis.

Cardiovascular diabetology·2025
Same author

A Bivalent Protease-Activated Receptor-Derived Peptide Mimics Neuronal Anti-Apoptotic Activity of Activated Protein C.

Bioengineering (Basel, Switzerland)·2025

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Microbiology

Background:

  • Bacitracin A is a cyclic peptide antibiotic.
  • Its mechanism of action involves inhibiting bacterial cell wall biosynthesis.
  • The precise molecular target interaction is crucial for understanding its efficacy.

Purpose of the Study:

  • To synthesize the enantiomer of bacitracin A using solid-phase total synthesis.
  • To evaluate the antibacterial potency of ent-bacitracin A compared to the natural enantiomer.
  • To investigate the stereochemical requirements for bacitracin's interaction with its target.

Main Methods:

  • Solid-phase total synthesis of ent-bacitracin A.
  • In vitro susceptibility assays against relevant bacterial strains.

Related Experiment Videos

  • Comparison of minimum inhibitory concentrations (MICs) between enantiomers.

    • Main Results:

    • Successful synthesis of ent-bacitracin A.
    • ent-Bacitracin A demonstrated equivalent in vitro potency to natural bacitracin A.
    • No significant difference in antibacterial activity was observed between the two enantiomers.

    Conclusions:

    • The antibacterial activity of bacitracin is not dependent on its chirality.
    • This supports the hypothesis that bacitracin targets bactoprenylpyrophosphate, an achiral lipid carrier.
    • The findings provide insights into the structure-activity relationship of bacitracin.